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Organelle-specific single-molecule imaging of ␣4␤2 nicotinic
receptors reveals the effect of nicotine on receptor assembly
and cell-surface trafficking
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Nicotinic acetylcholine receptors (nAChRs) assemble in the
endoplasmic reticulum (ER) and traffic to the cell surface as
pentamers composed of ␣ and ␤ subunits. Many nAChR subtypes can assemble with varying subunit ratios, giving rise to
multiple stoichiometries exhibiting different subcellular localization and functional properties. In addition to the endogenous
neurotransmitter acetylcholine, nicotine also binds and activates nAChRs and influences their trafficking and expression on
the cell surface. Currently, no available technique can specifically elucidate the stoichiometry of nAChRs in the ER versus
those in the plasma membrane. Here, we report a method
involving single-molecule fluorescence measurements to determine the structural properties of these membrane proteins after
isolation in nanoscale vesicles derived from specific organelles.
These cell-derived nanovesicles allowed us to separate single
membrane receptors while maintaining them in their physiological environment. Sorting the vesicles according to the
organelle of origin enabled us to determine localized differences
in receptor structural properties, structural influence on transport between organelles, and changes in receptor assembly
within intracellular organelles. These organelle-specific nanovesicles revealed that one structural isoform of the ␣4␤2 nAChR
was preferentially trafficked to the cell surface. Moreover, nicotine altered nAChR assembly in the ER, resulting in increased
production of the receptor isoform that traffics more efficiently
to the cell surface. We conclude that the combined effects of the
increased assembly of one nAChR stoichiometry and its preferential trafficking likely drive the up-regulation of nAChRs on
the cell surface upon nicotine exposure.

Nicotinic acetylcholine receptors (nAChRs)3 assemble in the
endoplasmic reticulum (ER) and traffic to the cell surface as
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pentamers composed of ␣ (␣2-␣10) and ␤ (␤2-␤4) subunits
(1–5). Many subtypes of these receptors can assemble with
varying ratios of subunits, giving rise to multiple stoichiometries that exhibit different subcellular localization and functional properties (6 –9). In addition to the endogenous neurotransmitter acetylcholine, nicotine also binds to and activates
these receptors. It has been shown that nicotine influences the
trafficking of nAChRs, resulting in increased expression on the
cell surface (10 –14). It has also been proposed that nicotine and
other ligands alter the assembly of the ␣4␤2 nicotinic receptor,
resulting in a decrease in the low-sensitivity stoichiometry,
(␣4)3(␤2)2, and an increase in the high-sensitivity stoichiometry, (␣4)2(␤2)3 (8, 15–18). Until now, no techniques were capable of specifically determining the stoichiometry of receptors in
the ER versus those on the plasma membrane. We developed a
single-molecule technique that allowed us to differentiate
between receptors localized in the ER and plasma membrane to
quantify the stoichiometry of individual receptors (Fig. 1).
Single-molecule fluorescence measurements are widely utilized to investigate protein dynamics including the detection of
conformational changes, stoichiometry, and protein mobility
(17, 19, 20). Experiments with this level of detail are only feasible after purification of the protein from its physiological cellular environment (21, 22). This type of purification is not achievable for many types of membrane proteins, which lose their
structural and functional integrity when removed from their
native cellular environment. This restricts single-molecule
studies to a small number of membrane proteins. Other techniques, such as single-molecule pulldown, have also been used
to capture proteins from cellular systems extending single-molecule studies to a wider range of proteins (19, 23, 24). Still, one
of the primary limitations to applying these current approaches
to membrane receptors is that organelle-specific information is
lost during protein purification. Membrane proteins are
synthesized in the ER and then trafficked to the cell surface
through the secretory pathway. Assembly of individual subunits that comprise oligomeric membrane proteins also takes
place in the ER prior to transport to the cell surface. Understanding drug-induced changes in the distribution of protein
isoforms between the ER and plasma membrane is vital to
determining how moderately different structural properties
can vastly impact functional properties. Isolation of individual
total internal reflection fluorescence; PMCA, plasma membrane calcium
ATPase; ROI, region of interest.
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Figure 1. Schematic showing the generation of organelle-specific nanovesicles containing a single nAChR. Cells expressing fluorescently labeled
membrane receptors are expressed throughout the ER and on the plasma membrane. Nitrogen cavitation is used to fragment the cells forming small
membrane domains from cellular organelles. These membrane domains spontaneously form nanoscale vesicles. The domains and subsequent vesicles are
small enough that there is a low probability of more than one receptor being encapsulated. The resulting vesicles have the same membrane properties as the
organelle of origin, thus maintaining a physiological environment. Differences in the densities between the organelle membranes are used to separate them
via gradient centrifugation. Vesicles are isolated on glass substrates for TIRF imaging.

membrane receptors in cell-derived nanoscale vesicles composed of original membranes enables the separation of receptors based on organelle (25, 26). Investigation of oligomeric
proteins from specific organelles at a single-molecule level provides a way to distinguish between different structural and
functional populations of these proteins, allowing the effect of
changes in assembly on protein trafficking to be directly
studied.
Here we report a novel approach that enables us to perform
organelle-specific single-molecule studies of membrane proteins. We can effectively select populations from the ER and the
plasma membrane to quantify properties such as the distribution of stoichiometric assemblies of oligomeric proteins. We
applied this technique to study nicotine-induced changes in the
assembly of ␣4␤2 nAChRs in the ER and changes in trafficking
to the cell surface.

Results
Ligand-induced up-regulation of ␣4␤2 receptors
Nicotine and several other nicotinic receptor ligands have
been shown to up-regulate the number of receptors on the cell
surface. It has been hypothesized that this up-regulation is connected to changes in receptor stoichiometry (18, 27). We first
evaluated a series of ligands to determine whether they altered
the expression and trafficking of ␣4␤2 by using a pH-sensitive
fluorophore, super ecliptic pHluorin (SEP) (11, 28, 29). The SEP
label was genetically incorporated into the protein sequence of
the receptor so that it was on the luminal side of the ER and the
extracellular side of the plasma membrane (Fig. 2, A and B). SEP
is fluorescent at neutral pH and quenched at acidic pH. Thus,
receptors in the ER and plasma membrane will exhibit fluorescence, whereas receptors in the Golgi and trafficking vesicles
are not fluorescent. Using total internal refection fluorescence
microscopy, we measured ligand-induced up-regulation of
␣4␤2 expression on the plasma membrane as an increase in
plasma membrane integrated density (PMID) and a change in
the distribution between the ER and plasma membrane (%PM)
as compared with control cells (26, 30). Exposure to nicotine or
cytisine resulted in a 2.5-fold increase, varenicline yielded a
2-fold increase, and bupropion resulted in a 1.5-fold increase in
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␣4␤2 expression on the cell surface (Fig. 2C). Additionally, the
intracellular distribution of ␣4␤2 between the plasma membrane and peripheral ER (%PM) shifted toward the plasma
membrane upon exposure to each of these ligands (Fig. 2D).
Comparisons between the ligands showed that nicotine provides the highest level of up-regulation in terms of expression
and distribution toward the plasma membrane.
Ligand-induced changes in ␣4␤2 assembly
To determine whether ligands that up-regulated nicotinic
receptors also changed their assembly, we then generated
whole-cell nanovesicles from cells expressing ␣4GFP ␤2wt
nAChRs (Fig. 3A) and examined the distribution of the two
possible ␣4␤2 isoforms, (␣4GFP)2(␤2)3 and (␣4GFP)3(␤2)2.
Nanovesicles were derived from cells both in the presence and
absence of the nicotinic ligands. Single receptors were then isolated into membrane-derived vesicles via nitrogen cavitation,
immobilized on a glass surface, and imaged using total internal
reflection fluorescence (TIRF) microscopy. A representative
image of isolated vesicles is shown in Fig. 3B. We then determined the number of photobleaching events (31–33) from the
intensity time traces recorded for the fluorescence of each
nanovesicles (Fig. 3, C and D). The assignment of the stoichiometric distribution is complicated by the fact that a small fraction of GFP exists in a non-fluorescent state (25, 34). Additionally, the observed distribution of photobleaching events arises
from a combination of (␣4GFP)2(␤2)3 and (␣4GFP)3(␤2)2 stoichiometries. To account for these factors, the observed distribution was fit to two binomial distributions, corresponding to
the distributions of the photobleaching events of (␣4GFP)2(␤2)3
and (␣4GFP)3(␤2)2. They were weighted iteratively to determine the contribution of each stoichiometry. Results from
these unsorted vesicles provided a measure of the whole-cell
distribution of ␣4␤2 stoichiometries. In the absence of any
ligand, we observed a distribution of 41% (␣4)2(␤2)3 and 59%
(␣4)3(␤2)2 (Fig. 4A). The presence of nicotine shifted the distribution of stoichiometry to 59% (␣4)2(␤2)3 and 41% (␣4)3(␤2)2
(Fig. 4B). A comparison of all ligands showed that each altered
the assembly toward (␣4)2(␤2)3 with cytisine increasing to 50%,
varenicline increasing to 54%, and bupropion increasing to 55%
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Figure 2. Ligand-induced up-regulation of nAChRs. A and B, schematics showing that TIRF imaging of SEP, a pH-sensitive analog of GFP, is used to determine
the expression and distribution of receptors between the ER and plasma membrane. SEP was genetically encoded into the ␣4 subunit to generate an ␣4-SEP
construct. The ␣4-SEP ␤2-wt nicotinic receptors were expressed in N2a cells and imaged under TIRF. A, when the pH of the extracellular solution (ECS) was
maintained at 7.4, receptors both in the ER and in the plasma membrane were observable. The observed fluorescence intensity is due to both the ER and
plasma membrane receptor populations. B, when the extracellular solution was replaced with a pH 5.4 solution, all SEP on the plasma membrane transition to
a non-fluorescent state, and only the receptors within the ER are visible. C, the integrated density of ␣4␤2 on the plasma membrane increased from ⬃2.5 ⫻ 106
in the absence of any compound to 7 ⫻ 106 in the presence of nicotine (Nic) or cytisine (Cyt). Varenicline (Var) and bupropion (Bup) both resulted in a 2-fold
increase in the integrated density on the plasma membrane demonstrating ligand-induced up-regulation. D, the percentage of the receptors present on the
plasma membrane increased from 21.5% for control cells to 30 – 40% for all nicotinic receptor ligands, showing a shift in distribution of receptors toward the
plasma membrane (n ⫽ 61, 47, 42, 38, 51). The data are mean values ⫾ S.D.). ***, p ⬍ 0.001. Integrated density (average fluorescence intensity ⫻ area) is the total
gray values background within a region of interest that encompasses a cell. PMID is obtained by subtracting the integrated density of pH 5 image of a cell from
pH 7 image of the same cell.

of the high-sensitivity stoichiometry (Fig. 4, C–E). The
observed distribution of bleaching steps is shown in Table 1.
Organelle-specific stoichiometry of ␣4␤2
We isolated nanovesicles and then sorted them via gradient
centrifugation into those derived from the ER and plasma
membrane (Fig. 1). Differences in the density of endogenous ER
and plasma membrane allow nanovesicles originating from
these organelles to be separated using a density gradient (35).
We verified the separation of vesicles using organelle-specific
antibodies via Western blot analysis. The ER marker, anti-calnexin, was only found in the three fractions with the highest
density, whereas the PM marker, anti-plasma membrane calcium ATPase (PMCA) or anti-Na⫹/K⫹ ATPase was found in
fractions with the lowest density (Fig. 5). We utilized this organelle-specific approach to distinguish between changes in receptor stoichiometry during assembly versus altered trafficking.

Because nicotinic receptors are synthesized in the ER, differences in assembly are reflected in the stoichiometry of this
population. Receptors are trafficked to the cell surface after
assembly; thus, a change in the stoichiometry on the plasma
membrane reflects preferential trafficking or increased stability
on the cell surface. We performed separate single-molecule
studies on both the ER and plasma membrane-specific nanovesicles. Single-molecule photobleaching analysis relies on the
observation of single step bleaching events of GFP where each
bleaching event corresponds to a single subunit. Our results
using GFP-labeled ␣ subunits showed that the predominately
expressed stoichiometry of ␣4␤2 nAChRs depends on the subcellular region. Receptors encapsulated in nanovesicles derived
from the ER show that in the absence of nicotine, ␣4␤2 nAChRs
predominately assemble with the low-sensitivity stoichiometry
of (␣4)3(␤2)2. The distribution of photobleaching events from
the ER resident ␣4␤2 nAChRs fit to a theoretical distribution
J. Biol. Chem. (2017) 292(51) 21159 –21169
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Figure 3. Single-molecule photobleaching to determine nAChR stoichiometry. A, representative mouse N2a cell expressing GFP-labeled nicotinic receptors in TIRF. B, representative TIRF image of isolated nanovesicles containing individual GFP-labeled receptors on a glass substrate. C and D, representative time
traces of two (C) and three (D) photobleaching steps for GFP-labeled nicotinic receptors, corresponding to two or three GFP-labeled ␣4 subunits, respectively.

Figure 4. Whole-cell evaluation of (␣4)2(␤2)3 versus (␣4)3(␤2)2 assembly upon exposure smoking cessation agents. Expected distributions of one, two,
and three photobleaching steps were obtained by weighting two binomial distributions. A 2 goodness-of-fit test was used to verify expected and observed
distributions of two and three GFP-labeled ␣4 subunits. A, in the absence of a pharmacological agent, the ␣4␤2 population exists as 41% (␣4)2(␤2)3 and 59%
(␣4)3(␤2)2. B, 500 nM nicotine alters the ratio of isoforms to 59% (␣4)2(␤2)3 and 41% (␣4)3(␤2)2. C, 500 nM cytisine shifts the stoichiometry to 50% high-sensitivity
receptors. D, 500 nM varenicline shifts the distribution to 54% high-sensitivity receptors. E, 500 nM bupropion shifts the stoichiometry to 55% high-sensitivity
receptors, (␣4)2(␤2)3. The error bars for the subunit distribution are based on counting events and are calculated as the square root of the counts.

21162 J. Biol. Chem. (2017) 292(51) 21159 –21169
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Table 1
The observed distribution of bleaching steps for whole cell nanovesicles expressing ␣4␤2

Control
Nicotine
Cytisine
Varenicline
Bupropion

Vesicles
counted

One
step

Two
steps

Three
steps

Four
steps

767
192
357
833
1089

53
22
41
94
102

386
112
187
459
598

328
58
130
280
389

54
9
17
30
43

Figure 5. Western blots verifying separation of ER and plasma
membrane– derived nanovesicles. Anti-calnexin was used an ER marker to
identify nanovesicles originating from the ER. Anti-PMCA was used to detect
nanovesicles formed from the plasma membrane. Calnexin is detected in
higher density fractions when vesicles are formed at 250 p.s.i. (A) and at
600 p.s.i. (B). Minimal PMCA is detected at fragmentation of 250 p.s.i. (C) but
are localized to lower density fractions upon swelling with a hypotonic solution and higher cavitation pressure of 600 p.s.i. (D). ER-specific nanovesicles
are collected from fraction 2 after 250 p.s.i. Plasma membrane–specific nanovesicles are collected from fraction 7 after formation at 600 p.s.i.

weighted for 30% (␣4)2(␤2)3 and 70% (␣4)3(␤2)2 (Fig. 6A). Single-molecule analysis of isolated ␣4␤2 nAChRs encapsulated in
nanovesicles derived from the plasma membrane had a higher
fraction of the high-sensitivity isoform. This fit to 54%
(␣4)2(␤2)3 and 46% (␣4)3(␤2)2 is shifted from the distribution
observed in the ER, suggesting that the two isoforms traffic to
the cell surface with different efficiencies (Fig. 6B). The
observed distribution of bleaching steps is shown in Table 2.
Nicotine changes the stoichiometry of ␣4␤2 in the ER
We next prepared ER and plasma membrane–specific vesicles from cells expressing ␣4␤2 in the presence of 500 nM nicotine. We observed a clear nicotine-induced shift in the stoichiometry of ER resident ␣4␤2 receptors (Fig. 6C). When nicotine
was present, single-molecule bleaching step analysis showed
the majority of endoplasmic ␣4␤2 assembled as the high-sensitivity isoform, fitting a 55% (␣4)2(␤2)3 and 45% (␣4)3(␤2)2
distribution (Fig. 6C). This shift from the stoichiometry seen in
the absence of nicotine indicates that nicotine drives the assembly of the high-sensitivity isoform, (␣4)2(␤2)3. Although some
groups have previously hypothesized that nicotine alters the
assembly of ␣4␤2 receptors (8, 9, 36, 37), these organelle-specific single-molecule studies allowed us to directly observe the
process of nicotine altering the assembly of receptors in the ER
for the first time. In addition to nicotine altering the assembly of
␣4␤2 within the ER, the percentage of the high-sensitivity

(␣4)2(␤2)3 stoichiometry on the plasma membrane was also
increased (Fig. 6D). After exposure to nicotine, the distribution
of photobleaching events obtained from plasma membrane–
resident ␣4␤2 nicotinic receptors was fit to a distribution of
70% (␣4)2(␤2)3 and 30% (␣4)3(␤2)2 (Fig. 6D).
Biased transfection to validate nicotine-induced shifts in
receptor stoichiometry
Our studies indicate that nicotine induces a shift toward the
assembly of the high-sensitivity stoichiometry in both the ER
and the plasma membrane. Biased transfection has previously
been used to induce a shift stoichiometry in that mimics that
seen with nicotine (38, 39). We performed a set of control studies to verify that in our experiments we could observe a shift in
stoichiometry in the ER and the plasma membrane. We transfected HEK-293T cells with a 1:10 ratio of ␣4-GFP:␤2-wt plasmids and generated vesicles from whole cells, the ER, and
plasma membrane. Single-molecule photobleaching analysis
studies of the unsorted receptors showed 73% (␣4)2(␤2)3 and
27% (␣4)3(␤2)2 (Fig. 7A). The ER– originated receptors exhibited 67% (␣4)2(␤2)3 and 33% (␣4)3(␤2)2 (Fig. 7B). The plasma
membrane population exhibited 82% (␣4)2(␤2)3 and 18%
(␣4)3(␤2)2 (Fig. 7C). These control studies verify that our technique is capable of independently measuring organelle-specific
shifts in stoichiometry.

Discussion
We have developed a new technique that allows us to perform organelle-specific single-molecule studies on membrane
proteins. We utilized this novel method to determine that
changes in nicotinic receptor stoichiometry related to nicotineinduced up-regulation (40) are likely driven by both changes in
the assembly in the ER and the preferential trafficking of the
high-sensitivity stoichiometry. The consequences of these
changes are an increase in the number of receptors both in the
ER and on the plasma membrane, as well as a shift in stoichiometric distribution toward the high-sensitivity assembly. Previous studies to measure ER specific changes in stoichiometry
have primarily been limited by a lack of existing techniques that
are capable of directly quantifying subcellular specific structural assemblies of complex proteins in a physiological cellular
environment. The isolation of membrane proteins in organellespecific nanovesicles provides a snapshot of membrane protein
assembly in each subcellular location at the time the vesicles are
generated. We observed that nicotine, cytisine, varenicline, and
bupropion all up-regulated the number of receptors on the cell
surface. We also observed that these same compounds all
altered the stoichiometry of ␣4␤2 nAChRs toward the highsensitivity stoichiometry. Nicotine induced the largest increase
in membrane expression and the largest shift toward the
high-sensitivity stoichiometry, (␣4)2(␤2)3. The only previous
single-molecule study of ␣4␤2 stoichiometry on the plasma
membrane showed that cytisine elicited a shift toward the lowsensitivity stoichiometry in contrast to our findings (17). This
previous study only examined the stoichiometry in the very tip
of filopodia projected into 150 –200-nm apertures. This
restricted studies to a specialized surface domain likely
accounting for the differences seen here. Our studies sample
J. Biol. Chem. (2017) 292(51) 21159 –21169
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Figure 6. Single-molecule bleaching step analysis shows organelle-specific differences in ␣4␤2 nAChR isoforms. A, the observed ratio of vesicles
showing one, two, or three steps was 0.057, 0.43, and 0.51, respectively (blue columns). These observed values were then fit to a 30:70 (high-sensitivity:lowsensitivity) stoichiometry. The fit was verified using a 2 goodness-of-fit analysis. B, the expression of ␣4␤2 nAChRs on the plasma membrane fit binomial
distributions weighted for 56% (␣4)2(␤2)3 and 44% (␣4)3(␤2)2. The observed fraction of vesicles showing one, two, or three bleaching steps was 0.12, 0.56, and
0.32, respectively. C, for ER resident receptors in the presence of nicotine, the observed fraction of one, two, and three bleaching steps were 0.086, 0.59, and
0.33, respectively. These observed values were then fit to a 55:45 distribution. D, the observed fraction of vesicles with one, two, or three bleaching steps were
0.11, 0.67, and 0.22, respectively. This was fit to a 70:30 distribution. The error bars for the subunit distribution are based on counting events and are calculated
as the square root of the counts.

Table 2
The observed distribution of bleaching steps for organelle-specific
nanovesicles expressing ␣4␤2

ER no drug
PM no drug
ER ⫹ 500 nM nicotine
PM ⫹ 500 nM nicotine

Vesicles
counted

One
step

Two
steps

Three
steps

Four
steps

458
545
465
883

26
26
40
100

199
199
273
592

233
233
152
191

14
1
27
18

the entire plasma membrane, providing a snap shot of the
whole population trafficked to the cell surface. Our results indicate that a wide variety of molecules with different pharmacological properties including agonists, partial agonists, and
antagonists all alter receptor assembly. This suggests a possible
connection between ligand-induced up-regulation and changes
in receptor assembly.
We then performed organelle-specific single-molecule studies of ␣4␤2 nAChRs in the presence and absence of nicotine to
resolve the connection between increased expression and
changes in stoichiometry. Comparing the distribution between
the low-sensitivity stoichiometry and high-sensitivity stoichiometry in the ER and plasma membrane showed a much larger
fraction of receptors exhibiting the high-sensitivity stoichiometry on the plasma membrane. This strongly suggests that the
high-sensitivity stoichiometry traffics to the cell surface more
efficiently than the low-sensitivity stoichiometry. We also
observed a shift in the ER stoichiometry toward the high-sen-
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sitivity isoform in the presence of nicotine. This suggests that
nicotine induces an intracellular change in the assembly of the
␣4␤2 nAChR. Biased transfection can shift the production of
the ␣4␤2 toward the high-sensitivity isoform. Single-molecule
photobleaching event analysis of vesicles from biased transfections experiments confirmed a shift toward the high-sensitivity
stoichiometry in vesicles originating from the ER. We observed
an even larger shift toward the high-sensitivity stoichiometry
on the plasma membrane. The presence of a higher proportion
of the high-sensitivity subtype in the plasma membrane compared with the ER verifies the preferential trafficking of the
(␣4)2(␤2)3 stoichiometry from the ER to plasma membrane.
Fig. 8 summarizes the fitted values from Fig. 6 to illustrate the
shift in stoichiometry. The observed differences in organelle
stoichiometry show that endogenous assembly in the ER favors
the low-sensitivity stoichiometry but that the high-sensitivity
isoform is preferentially trafficked from the ER to the plasma
membrane. Despite having a lower fraction in the ER, this preferential trafficking results in a larger fraction of high-sensitivity
receptors on the plasma membrane. Recent work by several
groups has proposed that nicotine acts as a pharmacological
chaperone either altering the assembly of nAChRs or influencing the trafficking. Previous studies have also shown that this
increases the numbers of ␣4␤2 nAChRs in the ER and the
plasma membrane. In these studies, we confirm that increased
numbers of receptors in the ER and altered assembly likely play

Altered stoichiometry of nAChRs

Figure 7. Biased transfection of ␣4␤2 to shift assembly toward the high sensitivity ((␣4)2(␤2)3) subtype in both the ER and the plasma membrane. The
expected distribution of one, two, and three photobleaching steps was determined by weighting two binomial distributions, and the fit of expected and
observed distribution was validated using a 2 goodness-of-fit test. The assigned weights represent the proportion of the high- and low-sensitivity stoichiometries. A, the observed photobleaching distribution of the receptors obtained from the whole-cell homogenate fit with the expected distribution obtained
with 73% (␣4)2(␤2)3 and 27% (␣4)3(␤2)2. B, the ER originated receptors exhibited a photobleaching step distribution which agreed with 67% (␣4)2(␤2)3 and
33% (␣4)3(␤2)2 stoichiometries. C, the stoichiometry for receptors from the plasma membrane was 82% (␣4)2(␤2)3 and 18% (␣4)3(␤2)2. The error bars for the
subunit distribution are based on counting events and are calculated as the square root of the counts.

␣4␤2 regulate preferential trafficking to the cell surface. These
intracellular loops contain a number of ER retention and ER
exit motifs, as well as sites that undergo post-translational modification in the secretory pathway (9, 41). These same processes
are also responsible for targeted trafficking to neuronal subcellular regions. Additionally, recycling from the Golgi back to the
ER has been shown to be necessary for nicotine-induced upregulation of some nicotinic receptor subtypes (16). It is likely that
differences in post-translational modification sites of the intracellular regions of ␣4 and ␤2 lead to the observed differences in trafficking between the two stoichiometries. Employment of our
organelle-specific single-molecule method enabled the distinction
between changes in trafficking compared with changes in assembly of ␣4␤2 nicotinic receptors to partially delineate the underlying mechanism of nicotine-induced up-regulation.
Figure 8. Organelle-specific single-molecule studies reveal a combination of endogenous preferential trafficking, and an intracellular
increase in assembly may be responsible for nicotine-induced up-regulation. A, organelle-specific single-molecule photobleaching step studies of
stoichiometry show that in the absence of nicotine, ␣4␤2 predominately
assembles into the 3␣ stoichiometry (blue) (70%). B, in the absence of nicotine, the 2␣ stoichiometry (green) is preferentially trafficked to the cell surface,
resulting in a higher proportion of receptors on the cell surface having the 2␣
stoichiometry. C, in the presence of nicotine, the intracellular assembly of
␣4␤2 is altered to favor the high-sensitivity, 2␣ isoform (green). D, the increase
in availability of the preferentially trafficked stoichiometry, (␣4)2(␤2)3, leads
to an even higher proportion of the 2␣ stoichiometry (green) on the plasma
membrane (70%).

roles in plasma membrane up-regulation but are only part of
the mechanism. Upon addition of nicotine, the assembly of subunits into a pentamer within the ER is altered to a higher ratio of
high-sensitivity receptors that can then be efficiently trafficked
to the cell surface. This suggests a mechanism of nicotine-induced plasma membrane up-regulation that is tied to increased
numbers of receptors in the ER, preferential trafficking, and a
change in assembly. The shift in assembly of ␣4␤2 nAChRs
within the ER upon exposure to nicotine toward the preferentially trafficked high-sensitivity isoform is likely responsible in
part for the nicotine-induced up-regulation that has been previously observed. It is possible that residues in the M1–M2 and
M3–M4 loops on the intracellular side of each of the subunits of

Experimental procedures
Plasmid constructs for fluorescently labeled nicotinic receptors (SEP and GFP) were generated as previously reported (26).
The ␣4-SEP construct was made by fusing the DNA sequence
of SEP to the 3⬘ end of the DNA sequence of the ␣4 subunit.
GFP constructs were made by inserting the label between the
M3 and M4 transmembrane segments of the ␣4 subunit. Both
constructs have been shown to produce functional receptors in
previous studies (25, 42, 43).
Cell culture
Undifferentiated mouse neuroblastoma 2a (N2a) cells were
employed to study the trafficking of ␣4␤2 nAChRs. N2a cells
were cultured and maintained with an N2a growth medium
(equal volume mixture of DMEM and OptiMEM supplemented
with 10% fetal bovine serum and 1% penicillin and streptomycin) at 37 °C with 5% CO2 in a humidified incubator. Approximately 90,000 N2a cells were plated on a poly-D-lysine– coated
glass-bottomed dish (35 mm in diameter; Cell E&G, San Diego,
CA). The coated dish was prepared by incubating it with 0.1%
poly-D-lysine in sterile deionized water at 37 °C for 1 h. The
unbound poly-D-lysine was removed by rinsing with sterile
deionized water, and the dish was dried for 2 h in a biosafety
hood. After 16 –24 h, the N2a cells were transfected with 500 ng
J. Biol. Chem. (2017) 292(51) 21159 –21169
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of each ␣4-SEP and ␤2-wt plasmids with 2 l of Lipofectamine
2000 as described previously (26). Briefly, cells were transfected
for 24 h, followed by a 24-h incubation in growth media prior to
imaging. Transfection mix was prepared by incubating a mixture of 250 l of OptiMEM and 2 l of Lipofectamine 2000
transfection agent for 5 min at room temperature, followed by a
25-min room temperature incubation upon combination with a
mixture of 250 l of OptiMEM and 500 ng of each plasmid
DNA. The 500 l of transfection mix was added to preplated
cells in 1.5 ml OptiMEM. After 24 h, transfection medium
was replaced with N2a growth medium for an additional
24-h incubation. Transfected cells were imaged 48 h after
initial transfection. When applicable, 500 nM of each nicotinic ligand, (⫺)-nicotine hydrogen tartrate salt (⬎98%),
bupropion hydrochloride (⬎98%), varenicline tartrate, or
(⫺)-cytisine (⬎99%), was added to the transfection medium
and replenished later in the growth medium. Transfection
efficiency was generally 80% and was not significantly altered
by the presence of any of the ligands.
Total internal reflection fluorescence
The TIRF microscope system employed to visualize SEP or
GFP molecules was previously described (26, 44). Briefly, a
488-nm DPSS laser excitation source was directed toward the
back aperture of an objective (60⫻, 1.49 NA) mounted on an
inverted microscope (Olympus IX81). The angle of excitation
light was adjusted to obtain total internal reflection through the
objective using a stepper motor that translated the beam across
the back aperture of the objective. The emission was collected
though the objective, and a dichroic mirror was used to direct
the light to an EMCCD camera (Andor).
Receptor expression and distribution
For in vivo fluorescence imaging studies, the growth medium
of the transfected N2a cells was replaced with an extracellular
solution (10 mM HEPES, 10 mM D-glucose, 150 mM NaCl, 4 mM
KCl, 2 mM MgCl2, and 2 mM CaCl2) of pH 7.4. The dish was then
mounted on a translational stage, and the cells were located by
exciting the SEP molecules with a 488-nm laser (⬃1 milliwatt)
source. Images of cells were captured using an EMCCD camera
with a 200-ms exposure time. The extracellular solution was
then replaced with an identical solution of pH 5.4, followed by a
10-min stage-top incubation before capturing images of the
same cells. An open source software, ImageJ (National Institutes of Health) was employed to analyze the images. Background was subtracted using the rolling ball background subtraction with a diameter of 25 pixels. A freehand region of
interest (ROI) was drawn around a cell, and an intensity based
threshold was used to obtain an integrated density for each cell.
The integrated density of the cell at pH 5.4 (ER ID) is subtracted
from the integrated density of the same cell at pH 7.4 (total ID)
to calculate the relative number of receptors on the plasma
membrane or PMID. The percentage of receptors located on
the plasma membrane within the TIRF region of excitation
(%PM) is calculated by dividing the PMID by the total ID at pH
7.4, multiplied by 100. The data are reported as the means ⫾
S.D.
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Nanovesicle preparation
HEK-293T cells were cultured and maintained with a growth
medium (DMEM supplemented with 10% fetal bovine serum
and 1% penicillin and streptomycin) at 37 °C temperature with
5% CO2 in a humidified incubator. Three million HEK-293T
cells were plated in a Matrigel-coated T75 flask 16 –24 h prior
to transfection. The cells were transfected with 14 l of Lipofectamine 2000 and 3.5 g of each plasmid as previously
described (25, 26). For biased expression experiments, a 1:10
transfection ratio of ␣4-GFP:␤2-wt using 1 g of ␣4-GFP and
10 g of ␤2-wt was employed. Briefly, a mixture of 250 l of
OptiMEM and the above mentioned amount of ␣4-GFP and
␤2-wt plasmids was prepared. Separately, 14 l of Lipofectamine 2000 was added to 250 l of OptiMEM and incubated for 5 min at room temperature before being added to the
DNA mixture. This new mixture was incubated at room temperature for 25 min. Afterward, the transfection mixture was
added to the flask of HEK-293T cells. The following day,
vesicles were prepared from transfected cells as previously
described (25). Briefly, the cells underwent nitrogen cavitation
at 250 p.s.i. for 5 min while suspended in 5 ml of sucrose-HEPES
buffer supplemented with a protease inhibitor (250 mM
sucrose, 10 mM HEPES, 1 Pierce protease inhibitor mini tablet
per 10 ml of buffer (ThermoScientific), pH 7.5). Cell lysate was
then centrifuged at 4000 ⫻ g for 10 min. Supernatant was collected and centrifuged at 10,000 ⫻ g for 20 min. Supernatant
was again collected and centrifuged at 100,000 ⫻ g for 1 h. The
pellet was resuspended in 800 l of sucrose-HEPES buffer (250
mM sucrose, 10 mM HEPES, pH 7.5). Nanovesicles were stored
at ⫺80 °C until use.
Generation of ER and plasma membrane vesicles
HEK-293T cells were transfected as described above. After
transfection for 24 h, transfection mix was removed, and the
cells were rinsed once with PBS. To generate nanoscale plasma
membrane vesicles containing a single nAChR, transfected
cells were first swollen for 20 min in a hypotonic solution (10
mM NaCl, 10 mM Tris-HCl, 1.5 mM MgCl2, 0.2 mM CaCl2, pH
7.4) at 0 °C. To prepare both plasma membrane and
ER– derived vesicles, the cells were treated with 5 ml of 1⫻
Versene (Invitrogen), incubated at 37 °C for 5 min, and pelleted
by centrifugation at 200 ⫻ g for 5 min, as previously described.
The cell pellet was resuspended in 3 ml of sucrose buffer plus
protease inhibitors (250 mM sucrose, 10 mM HEPES, 1 Pierce
protease inhibitor mini tablet per 10 ml of buffer (ThermoScientific), pH 7.5) before undergoing nitrogen cavitation in a
nitrogen decompressor (Parr Instrument Company, Moline,
IL). To generate ER nanovesicles, the cells were pressurized to
⬃250 p.s.i. for 20 min. At this pressure, plasma membrane rupturing is minimal, and therefore nanoscale vesicle formation
from this organelle is negligible. To generate plasma membrane
nanovesicles, the cells were pressurized to ⬃600 p.s.i. for 20
min. The cell lysate was collected and dispensed onto an
OptiPrep gradient.
Separation of organelle-specific vesicles
A 9-fraction OptiPrep (60% (w/v) iodixanol in H2O; Accurate
Chemical & Scientific Corp., Westbury, NY) gradient was used

Altered stoichiometry of nAChRs
to purify organelle-specific nanovesicles. Gradient solutions of
OptiPrep were prepared by diluting the 60% stock solution to
30, 20, and 10% in sucrose-HEPES buffer (250 mM sucrose, 10
mM HEPES, pH 7.5) and stored at 4 °C. The gradient was prepared in an Ultra-Clear centrifuge tube (Beckman Coulter),
with 3 ml of the densest fraction added first. ER or plasma
membrane nanovesicles containing cell lysate, based on nitrogen pressure during cavitation, was dispensed on top of the 10%
fraction, before centrifugation at 112,000 ⫻ g for 1.5 h. After
centrifugation, nine 1–1.5-ml fractions, with density interfaces
in the same fraction, were collected using a peristaltic pump.
Tubing connected to the pump was vertically inserted into the
centrifuge tube so that the highest density fraction is collected
first. After fractionation, OptiPrep was removed from nanovesicles by centrifugation at 10,000 ⫻ g for 1 h.
Western blot analysis
Resuspended OptiPrep fractions containing membrane proteins were ran on a prepackaged NuPAGE 4 –12% Bis-Tris gel
(Life Technologies), followed by transfer to a nitrocellulose
membrane. The membrane was first blocked for 1 h with a
PBST solution (5% nonfat milk, 0.1% Tween in PBS). Primary
antibodies specific for calnexin (Santa Cruz, calnexin antibody
(H-70), catalog no. sc-11397) or PMCA (Santa Cruz, PMCA
antibody (D-1), catalog no. sc-271193) were added to the membrane in a 1:1000 dilution and incubated overnight at 4 °C.
Endogenous calnexin is solely found in the membrane of the
ER, whereas PMCA is expressed on the plasma membrane, thus
providing a means to identify fractions that consist of exclusively ER or plasma membranes. After overnight incubation,
primary antibodies were removed by four repeated 5-min
washes with PBST. Secondary rabbit antibody (calnexin) or
mouse antibody (PMCA) (Jackson ImmunoResearch) was
added in a 1:5000 dilution and incubated for 1 h at room temperature, followed by another series of four repeated 5-min
washes with PBST. Bands were visualized by addition of Western blotting substrate for chemiluminescence (Clarity; BioRad) on a Chemi-Doc system (Bio-Rad). To validate these
results, blots were repeated with a completely different set of
antibodies. For primary antibodies, we used 1:2000 diluted rabbit monoclonal anti-calnexin (catalog no. ab92573, Abcam) for
ER identification and 1:2000 diluted rabbit monoclonal antiNa,K-ATPase (catalog no. ab76020, Abcam) for plasma membrane identification. In both sets of orthogonal studies, the ER
and plasma membrane bands matched the expected molecular
weights.
Imaging nanovesicles
A 35-mm glass-bottomed dish was cleaned by sonicating the
dish in 5 M NaOH solution for 30 min at 45 °C and then in 0.1 M
HCl solution for 30 min at 45 °C. The dish was rinsed with
water, sprayed with 100% ethanol three times after each step,
and then dried using compressed air. Finally, the dishes were
treated in an oxygen plasma (21% oxygen for ⬃5 min). A biotinylated anti-GFP antibody functionalized glass-bottomed dish
was prepared by incubating a cleaned dish at room temperature
with 1 mg/ml Silane-PEG-Biotin in 95% ethanol for 30 min, 0.1
mg/ml NeutrAvidin in PBS (1⫻ PBS, pH 7.4) solution for 5 min,

and finally 1 g/ml biotinylated anti-GFP antibody in PBS for
15 min. Between each of the steps, the dish was rinsed three
times with 1⫻ PBS solution. Vesicles were immobilized on the
biotinylated anti-GFP antibody functionalized dish by adding
50 –200-fold diluted vesicles in PBS for 30 min at room temperature. The unbound vesicles were removed by rinsing with PBS,
and ⬃1 ml of PBS solution was added to the dish. The microscope setup employed to capture images for SEP based studies
was also utilized to obtain movies of about 1000 frames (100
ms of exposure time) during 488-nm laser excitation (⬃3
milliwatts).
Data analysis
A customized software package was written in Matlab to
populate time traces from the movies collected with immobilized vesicles. Briefly, the first 10 frames of a movie were combined together to make a composite frame, which was utilized
to find peaks with a user defined threshold level. A 3-pixel by
3-pixel ROI was selected for each peak position to obtain the
mean intensity of the ROI. A 5-pixel by 5-pixel ring around the
peak was selected, and the mean value of the pixels located on
the ring was considered as background that was subtracted
from the mean value of the ROI of the corresponding frame to
obtain a background subtracted mean intensity of the ROI.
Time traces for all peaks were stored in a temporary file. During
the initial evaluation, a time trace of the temporary file was
accepted if the difference of the mean of the intensities of first
20 frames and last 20 frames was more than twice the standard
deviation of last 20 frames. All time traces for the qualified
molecules were collected and stored for further analysis.
A photobleaching step was counted only if it lasted at least 1 s
and the intensity levels of a step and the next lower level had a
difference of at least twice the standard deviation of the lower
level. A time trace was considered to arise from a single-molecule if it showed at least one clear bleaching step. Each set of
data was independently analyzed at least twice, and the results
were compared.
Data fitting
The probability of observing a photobleaching event from a
GFP molecule is less than 1. Therefore, a binomial distribution
was employed to determine the distribution of the number of
photobleaching events observed from a population of GFP-labeled receptors. A general equation for observing k number of
photobleaching events from n number of GFP-labeled receptors can be written as,
F 共 k; n, p兲 ⫽

n!
pk共1 ⫺ p兲n⫺k
k!共n ⫺ k兲!

(Eq. 1)

where p is the probability of observing a photobleaching event
from a GFP-labeled subunit, which has been previously determined as 0.90 (25).
A matrix (M2) with the probabilities of obtaining one, two,
and three photobleaching events from two GFP containing
␣4␤2 nAChRs (i.e. (␣4-GFP)2(␤2-wt)3) can be written as follows.
M 2 ⫽ 关 F 共 1; 2, 0.9兲, F共2; 2, 0.9兲, 0兴
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Similarly, matrix M3, containing the probabilities of observing one, two, and three photobleaching events from three GFP
containing ␣4␤2 nAChRs (i.e. (␣4-GFP)3(␤2-wt)2), can be
expressed as shown in Equation 3.
M 3 ⫽ 关 F 共 1; 3, 0.9兲, F共2; 3, 0.9兲, F共3; 3, 0.9兲兴

(Eq. 3)

Because the probability of obtaining zero photobleaching
events from two or three GFP-labeled ␣4␤2 nAChRs can be
greater than zero, the probability distributions M2 and M3 were
normalized as follows,
M 2⬘ ⫽
M 3⬘ ⫽

冋

冋

F 共 1; 2, 0.9兲 F共2; 2, 0.9兲
,
,0
S2
S2

册

册

F 共 1; 3, 0.9兲 F共2; 3, 0.9兲 F共3; 3, 0.9兲
,
,
S3
S3
S3

5.

(Eq. 4)

6.

(Eq. 5)

7.

where M⬘2 and M⬘3 are normalized probability distribution
matrices corresponding to M2 and M3, respectively; S2 ⫽ F(1;
2,0.90) ⫹ F(2;2,0.90) ⫹ 0, and S3 ⫽ F(1;3,0.90) ⫹ F(2;3,0.90) ⫹
F(3;3,0.90).
Because the experimentally observed distribution emerged
from a mixture of (␣4-GFP)2(␤2-wt)3 and (␣4-GFP)3(␤2-wt)2
stoichiometries, a theoretical probability distribution (Tpd) was
computed by providing a weight to each normalized probability
matrix as follows,
T pd ⫽ a2 ⫻ M⬘2 ⫹ a3 ⫻ M⬘3

4.

(Eq. 6)

where a2 and a3 are the weights assigned to M⬘and M⬘3 distributions, respectively, and a2 ⫹ a3 ⫽ 1. Therefore, a2 and a3 are
the proportions of (␣4-GFP)2(␤2-wt)3 and (␣4-GFP)3(␤2-wt)2
stoichiometries, respectively. This probability distribution
(Tpd) was multiplied by total number of observed one, two, and
three photobleaching events to generate a theoretical distribution. A 2 goodness-of-fit test was employed to compare theoretical and observed distributions. The error bars for subunit
distribution are based on counting events and are calculated as
the square root of the counts (31). The values of a2 and a3 were
iteratively assigned and a 2 goodness-of-fit test statistics was
calculated for each set of a2 and a3. A customized Matlab script
was written to calculate a2 and a3 from the best 2 goodnessof-fit test statistics.
Author contributions—A. M. F.-L., F. H. M., and C. I. R. designed
the studies. A. M. F.-L. and F. H. M. performed the experiments.
F. H. M. wrote the analysis software for the single-molecule studies.
All authors reviewed the results and approved the final version of the
manuscript.

8.

9.

10.

11.

12.

13.

14.

15.

16.

17.

18.

References
1. Albuquerque, E. X., Pereira, E. F. R., Alkondon, M., and Rogers, S. W.
(2009) Mammalian nicotinic acetycholine receptors: from structure to
function. Physiol. Rev. 89, 73–120
2. Anand, R., Conroy, W. G., Schoepfer, R., Whiting, P., and Lindstrom, J.
(1991) Neuronal nicotinic acetylcholine-receptors expressed in Xenopus
oocytes have a pentameric quaternary structure. J. Biol. Chem. 266,
11192–11198
3. Lukas, R. J., Changeux, J. P., Le Novère, N., Albuquerque, E. X., Balfour,
D. J., Berg, D. K., Bertrand, D., Chiappinelli, V. A., Clarke, P. B., Collins,

21168 J. Biol. Chem. (2017) 292(51) 21159 –21169

19.

20.
21.

A. C., Dani, J. A., Grady, S. R., Kellar, K. J., Lindstrom, J. M., Marks, M. J.,
et al. (1999) International Union of Pharmacology: XX. Current status of
the nomenclature for nicotinic acetylcholine receptors and their subunits.
Pharmacol. Rev. 51, 397– 401
Eaton, J. B., Lucero, L. M., Stratton, H., Chang, Y., Cooper, J. F., Lindstrom,
J. M., Lukas, R. J., and Whiteaker, P. (2014) The unique ␣4⫹/⫺␣4 agonist
binding site in (␣4)3(␤2)2 subtype nicotinic acetylcholine receptors permits differential agonist desensitization pharmacology versus the
(␣4)2(␤2)3 subtype. J. Pharmacol. Exp. Ther. 348, 46 –58
Chatterjee, S., Santos, N., Holgate, J., Haass-Koffler, C. L., Hopf, F. W.,
Kharazia, V., Lester, H., Bonci, A., and Bartlett, S. E. (2013) The ␣5 subunit
regulates the expression and function of ␣4*-containing neuronal nicotinic acetylcholine receptors in the ventral-tegmental area. PLoS One 8,
e68300
Zwart, R., and Vijverberg, H. P. (1998) Four pharmacologically distinct
subtypes of ␣4␤2 nicotinic acetylcholine receptor expressed in Xenopus
laevis oocytes. Mol. Pharmacol 54, 1124 –1131
Moroni, M., Zwart, R., Sher, E., Cassels, B. K., and Bermudez, I. (2006)
␣4␤2 nicotinic receptors with high and low acetylcholine sensitivity: pharmacology, stoichiometry, and sensitivity to long-term exposure to nicotine. Mol. Pharmacol. 70, 755–768
Nelson, M. E., Kuryatov, A., Choi, C. H., Zhou, Y., and Lindstrom, J. (2003)
Alternate stoichiometries of ␣4␤2 nicotinic acetylcholine receptors. Mol.
Pharmacol. 63, 332–341
Srinivasan, R., Pantoja, R., Moss, F. J., Mackey, E. D., Son, C. D., Miwa, J.,
and Lester, H. A. (2011) Nicotine up-regulates ␣4␤2 nicotinic receptors
and ER exit sites via stoichiometry-dependent chaperoning. J. Gen.
Physiol. 137, 59 –79
Turner, J. R., Castellano, L. M., and Blendy, J. A. (2011) Parallel anxiolyticlike effects and upregulation of neuronal nicotinic acetylcholine receptors
following chronic nicotine and varenicline. Nicotine Tob. Res. 13, 41– 46
Richards, C. I., Srinivasan, R., Xiao, C., Mackey, E. D., Miwa, J. M., and
Lester, H. A. (2011) Trafficking of ␣4* nicotinic receptors revealed by
superecliptic phluorin. J. Biol. Chem. 286, 31241–31249
Ngolab, J., Liu, L., Zhao-Shea, R., Gao, G., Gardner, P. D., and Tapper, A. R.
(2015) Functional upregulation of ␣4* nicotinic acetylcholine receptors in
VTA GABAergic neurons increases sensitivity to nicotine reward. J. Neurosci. 35, 8570 – 8578
Walsh, H., Govind, A. P., Mastro, R., Hoda, J. C., Bertrand, D., Vallejo, Y.,
and Green, W. N. (2008) Upregulation of nicotinic receptors by nicotine
varies with receptor subtype. J. Biol. Chem. 283, 6022– 6032
Mukhin, A. G., Kimes, A. S., Chefer, S. I., Matochik, J. A., Contoreggi, C. S.,
Horti, A. G., Vaupel, D. B., Pavlova, O., and Stein, E. A. (2008) Greater
nicotinic acetylcholine receptor density in smokers than in nonsmokers: a
PET study with 2-18F-FA-85380. J. Nucl. Med. 49, 1628 –1635
Srinivasan, R., Henderson, B. J., Lester, H. A., and Richards, C. I. (2014)
Pharmacological chaperoning of nAChRs: a therapeutic target for Parkinson’s disease. Pharmacol. Res. 83, 20 –29
Henderson, B. J., Srinivasan, R., Nichols, W. A., Dilworth, C. N., Gutierrez,
D. F., Mackey, E. D., McKinney, S., Drenan, R. M., Richards, C. I., and
Lester, H. A. (2014) Nicotine exploits a COPI-mediated process for chaperone-mediated up-regulation of its receptors. J. Gen. Physiol. 143, 51– 66
Richards, C. I., Luong, K., Srinivasan, R., Turner, S. W., Dougherty, D. A.,
Korlach, J., and Lester, H. A. (2012) Live-cell imaging of single receptor
composition using zero-mode waveguide nanostructures. Nano Lett. 12,
3690 –3694
Fasoli, F., Moretti, M., Zoli, M., Pistillo, F., Crespi, A., Clementi, F., Mc
Clure-Begley, T., Marks, M. J., and Gotti, C. (2016) In vivo chronic nicotine
exposure differentially and reversibly affects upregulation and stoichiometry of ␣4␤2 nicotinic receptors in cortex and thalamus. Neuropharmacology 108, 324 –331
Jain, A., Liu, R., Ramani, B., Arauz, E., Ishitsuka, Y., Ragunathan, K., Park,
J., Chen, J., Xiang, Y. K., and Ha, T. (2011) Probing cellular protein complexes using single-molecule pull-down. Nature 473, 484 – 488
Ulbrich, M. H., and Isacoff, E. Y. (2007) Subunit counting in membranebound proteins. Nat. Methods 4, 319 –321
Lee, J., and Lee, T.-H. (2017) Single-molecule investigations on histone
H2A-H2B dynamics in the nucleosome. Biochemistry 56, 977–985

Altered stoichiometry of nAChRs
22. Banerjee, P. R., Moosa, M. M., and Deniz, A. A. (2016) Two-dimensional
crowding uncovers a hidden conformation of ␣-synuclein. Angew. Chem.
Int. Ed. Engl. 55, 12789 –12792
23. Husbands, A. Y., Aggarwal, V., Ha, T., and Timmermans, M. C. (2016) In
planta single-molecule pull-down reveals tetrameric stoichiometry of
HD-ZIPIII:LITTLE ZIPPER complexes. Plant Cell 28, 1783–1794
24. Rodgers, M. L., Paulson, J., and Hoskins, A. A. (2015) Rapid isolation and
single-molecule analysis of ribonucleoproteins from cell lysate by SNAPSiMPull. RNA 21, 1031–1041
25. Moonschi, F. H., Effinger, A. K., Zhang, X., Martin, W. E., Fox, A. M.,
Heidary, D. K., DeRouchey, J. E., and Richards, C. I. (2015) Cell-derived
vesicles for single-molecule imaging of membrane proteins. Angew. Chem.
Int. Ed. Engl. 54, 481– 484
26. Fox, A. M., Moonschi, F. H., and Richards, C. I. (2015) The nicotine metabolite, cotinine, alters the assembly and trafficking of a subset of nicotinic acetylcholine receptors. J. Biol. Chem. 290, 24403–24412
27. Marks, M. J., O’Neill, H. C., Wynalda-Camozzi, K. M., Ortiz, N. C., Simmons, E. E., Short, C. A., Butt, C. M., McIntosh, J. M., and Grady, S. R.
(2015) Chronic treatment with varenicline changes expression of four
nAChR binding sites in mice. Neuropharmacology 99, 142–155
28. Khiroug, S. S., Pryazhnikov, E., Coleman, S. K., Jeromin, A., Keinänen, K.,
and Khiroug, L. (2009) Dynamic visualization of membrane-inserted fraction of pHluorin-tagged channels using repetitive acidification technique.
BMC Neurosci. 10, 141
29. Lin, D. T., Makino, Y., Sharma, K., Hayashi, T., Neve, R., Takamiya, K., and
Huganir, R. L. (2009) Regulation of AMPA receptor extrasynaptic insertion by 4.1N, phosphorylation and palmitoylation. Nat. Neurosci. 12,
879 – 887
30. Zhang, Z., Baksh, M. M., Finn, M. G., Heidary, D. K., and Richards, C. I.
(2017) Direct measurement of trafficking of the cystic fibrosis transmembrane conductance regulator to the cell surface and binding to a chemical
chaperone. Biochemistry 56, 240 –249
31. Bharill, S., Fu, Z., Palty, R., and Isacoff, E. Y. (2014) Stoichiometry and
specific assembly of best ion channels. Proc. Natl. Acad. Sci. U.S.A. 111,
6491– 6496
32. Durisic, N., Godin, A. G., Wever, C. M., Heyes, C. D., Lakadamyali, M., and
Dent, J. A. (2012) Stoichiometry of the human glycine receptor revealed by
direct subunit counting. J. Neurosci. 32, 12915–12920
33. Hastie, P., Ulbrich, M. H., Wang, H. L., Arant, R. J., Lau, A. G., Zhang, Z.,
Isacoff, E. Y., and Chen, L. (2013) AMPA receptor/TARP stoichiometry

34.

35.

36.

37.

38.
39.

40.
41.

42.

43.

44.

visualized by single-molecule subunit counting. Proc. Natl. Acad. Sci.
U.S.A. 110, 5163–5168
Foo, Y. H., Naredi-Rainer, N., Lamb, D. C., Ahmed, S., and Wohland, T.
(2012) Factors affecting the quantification of biomolecular interactions by fluorescence cross-correlation spectroscopy. Biophys. J. 102,
1174 –1183
Li, X., and Donowitz, M. (2014) Fractionation of subcellular membrane
vesicles of epithelial and non-epithelial cells by OptiPrep density gradient
ultracentrifugation. Methods Mol. Biol. 1174, 85–99
Kuryatov, A., Luo, J., Cooper, J., and Lindstrom, J. (2005) Nicotine acts as
a pharmacological chaperone to up-regulate human ␣4␤2 acetylcholine
receptors. Mol. Pharmacol. 68, 1839 –1851
Mazzo, F., Pistillo, F., Grazioso, G., Clementi, F., Borgese, N., Gotti, C., and
Colombo, S. F. (2013) Nicotine-modulated subunit stoichiometry affects
stability and trafficking of ␣3 ␤4 nicotinic receptor. J. Neurosci. 33,
12316 –12328
Morales-Perez, C. L., Noviello, C. M., and Hibbs, R. E. (2016) X-ray structure of the human ␣4␤2 nicotinic receptor. Nature 538, 411– 415
Morales-Perez, C. L., Noviello, C. M., and Hibbs, R. E. (2016) Manipulation of subunit stoichiometry in heteromeric membrane proteins. Structure 24, 797– 805
Henderson, B. J., and Lester, H. A. (2015) Inside-out neuropharmacology
of nicotinic drugs. Neuropharmacology 96, 178 –193
Amici, S. A., McKay, S. B., Wells, G. B., Robson, J. I., Nasir, M., Ponath, G.,
and Anand, R. (2012) A highly conserved cytoplasmic cysteine residue in
the ␣4 nicotinic acetylcholine receptor is palmitoylated and regulates protein expression. J. Biol. Chem. 287, 23119 –23127
Fox-Loe, A. M., Dwoskin, L. P., and Richards, C. I. (2016) Nicotinic acetylcholine receptors as targets for tobacco cessation therapeutics: cuttingedge methodologies to understand receptor assembly and trafficking.
Neuromethods 117, 119 –132
Srinivasan, R., Richards, C. I., Xiao, C., Rhee, D., Pantoja, R., Dougherty,
D. A., Miwa, J. M., and Lester, H. A. (2012) Pharmacological chaperoning
of nicotinic acetylcholine receptors reduces the endoplasmic reticulum
stress response. Mol. Pharmacol. 81, 759 –769
Araki, Y., Lin, D. T., and Huganir, R. L. (2010) Plasma membrane
insertion of the AMPA receptor GluA2 subunit is regulated by NSF
binding and Q/R editing of the ion pore. Proc. Natl. Acad. Sci. U.S.A.
107, 11080 –11085

J. Biol. Chem. (2017) 292(51) 21159 –21169

21169

Organelle-specific single-molecule imaging of α4β2 nicotinic receptors reveals the
effect of nicotine on receptor assembly and cell-surface trafficking
Ashley M. Fox-Loe, Faruk H. Moonschi and Christopher I. Richards
J. Biol. Chem. 2017, 292:21159-21169.
doi: 10.1074/jbc.M117.801431 originally published online October 26, 2017

Access the most updated version of this article at doi: 10.1074/jbc.M117.801431
Alerts:
• When this article is cited
• When a correction for this article is posted
Click here to choose from all of JBC's e-mail alerts
This article cites 44 references, 23 of which can be accessed free at
http://www.jbc.org/content/292/51/21159.full.html#ref-list-1

